PerPlexity Medical - Diagnostics and Research's Stock Coverage
| WGSGeneDx Holdings | Nov 01, 2026 | HOLD | Reiterated | $68.00 | 23Ratings | ― | ― | |
| NDRAENDRA Life Sciences | Nov 01, 2026 | HOLD | Reiterated | $4.50 | 64Ratings | -24.17% | ||
| MYGNMyriad Genetics | Nov 01, 2026 | HOLD | Reiterated | $6.50 | 64Ratings | -58.40% | ||
| IMDXInsight Molecular Diagnostics | Nov 01, 2026 | HOLD | Reiterated | $3.00 | 42Ratings | ― | ― | |
| IDXGInterpace Diagnostics Group | Nov 01, 2026 | HOLD | Reiterated | $6.00 | 74Ratings | +11.80% | ||
| BNRBurning Rock Biotech | Nov 01, 2026 | HOLD | Reiterated | $10.50 | 76Ratings | ― | ― | |
| BDSXBiodesix | Nov 01, 2026 | HOLD | Reiterated | $24.00 | 68Ratings | -40.40% | ||
| AAgilent | Nov 01, 2026 | BUY | Reiterated | $202.00 | 64Ratings | +22.70% | ||
| XGNExagen | Oct 31, 2026 | HOLD | Reiterated | $8.50 | 62Ratings | +46.10% | ||
| WATWaters | Oct 31, 2026 | BUY | Reiterated | $550.00 | 47Ratings | +17.00% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Medical - Diagnostics and Research activity FAQ
What is the performance of PerPlexity Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by PerPlexity Medical - Diagnostics and Research is 66.36%, and the average return per transaction is 9.10%.
What stocks does PerPlexity Medical - Diagnostics and Research cover?
PerPlexity Medical - Diagnostics and Research mostly covers Agilent, Biodesix, Burning Rock Biotech stocks.
What was PerPlexity Medical - Diagnostics and Research's most profitable rating?
PerPlexity Medical - Diagnostics and Research’s most profitable rating was a buy on CareDx stock on Apr 29, 2026. The return on the trade was 320.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here